Effect of an AI-Supported Chatbot on Nursing Students' Clinical Decision-Making in Gynecological Oncology
4. september 2026 opdateret af: Ahsen Demirhan, Sakarya University
The Effect of an Artificial Intelligence-Supported Educational Chatbot on Nursing Students' Knowledge of Gynecologic Cancers and Clinical Decision-Making Skills: A Randomized Controlled Trial
This randomized controlled trial aims to determine the effect of an artificial intelligence (AI)-supported educational chatbot (OSCE Coach Platform) on nursing students' knowledge of gynecologic cancers and their self-reported clinical decision-making skills.
Third-year undergraduate nursing students will be randomized into either an intervention group, utilizing the AI-supported chatbot, or a control group, receiving conventional education.
Both groups will be assessed before and after the intervention.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
110
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Turkey
-
Sakarya, Turkey, Tyrkiet (Türkiye), 54050
- Sakarya University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Enrolled as a third-year undergraduate nursing student.
- Successfully completed the Obstetrics and Gynecology Nursing (Women's Health and Diseases Nursing) course.
- Volunteered to participate and provided digital informed consent.
Exclusion Criteria:
- No additional exclusion criteria.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: AI-Supported Chatbot Group
Participants in this group access the web-based OSCE Coach platform.
They complete five sequential AI-supported virtual patient scenarios focusing on cervical, endometrial, ovarian, vulvar, and vaginal cancers.
The system provides mastery-based progression and immediate individualized feedback using a predefined five-domain rubric.
|
A custom web-based educational platform combining AI-supported virtual patient interaction with standardized case scenarios, predefined clinical tasks, and immediate rubric-based feedback.
|
|
Ingen indgriben: Conventional Education Group
Participants in this group continue their standard Women's Health and Diseases Nursing course.
They complete a standard virtual patient assessment without receiving access to the AI-supported training scenarios, individualized feedback, or mastery-based practice.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Clinical Decision Making in Nursing Scale-Turkish Version (CDMNS-Tr) Score
Tidsramme: Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.
|
The CDMNS-Tr is a 40-item scale assessing self-reported clinical decision-making.
Items are rated on a 5-point Likert scale ranging from 1 (never) to 5 (always), with eighteen negatively worded items being reverse-scored.
Total scores range from 40 to 200, with higher scores indicating a higher self-perception of clinical decision-making abilities.
|
Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Gynecological Oncology Knowledge Test Score
Tidsramme: Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.
|
A 15-item multiple-choice test developed to evaluate cognitive learning outcomes regarding gynecological oncology and nursing care.
Each correct answer is awarded 1 point, while incorrect or blank answers receive 0 points.
Total scores range from 0 to 15, with higher scores indicating a higher level of knowledge.
|
Baseline (Day 1, before the assigned study procedures) and immediately after completion of the assigned study procedures on Day 1.
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
20. juni 2026
Primær færdiggørelse (Faktiske)
10. juli 2026
Studieafslutning (Faktiske)
1. september 2026
Datoer for studieregistrering
Først indsendt
2. september 2026
Først indsendt, der opfyldte QC-kriterier
4. september 2026
Først opslået (Faktiske)
8. september 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
10. september 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
4. september 2026
Sidst verificeret
1. september 2026
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 02.09.2026
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .